2009
DOI: 10.1213/ane.0b013e31819385e1
|View full text |Cite
|
Sign up to set email alerts
|

Cytotoxicity of Local Anesthetics in Human Neuronal Cells

Abstract: LAs can cause rapid cell death, which is primarily due to necrosis. Lidocaine and bupivacaine can trigger apoptosis with either increased time of exposure or increased concentration. These effects might be related to postoperative neurologic injury. Lidocaine, linked to the highest incidence of transient neurological symptoms, was not the most toxic LA, whereas bupivacaine, a drug causing a very low incidence of transient neurological symptoms, was the most toxic LA in our cell model. This suggests that cytoto… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

14
148
0
8

Year Published

2010
2010
2022
2022

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 215 publications
(183 citation statements)
references
References 42 publications
14
148
0
8
Order By: Relevance
“…Compounds shutting down intracellular reactions 403 concentrations of these drugs might contribute to clinical toxicity or side-effects, as reported previously (Perez-Castro et al, 2009;Motohashi, 2006;Vianna et al, 2001). The yeast system may contribute to elucidating the mechanisms of action and toxicity of the paralysing agents at the cellular level, and to the design of novel drugs, because the system can provide a genetic approach as well as easy and detailed evaluation.…”
Section: Compounds Shutting Down Intracellular Reactionssupporting
confidence: 57%
See 1 more Smart Citation
“…Compounds shutting down intracellular reactions 403 concentrations of these drugs might contribute to clinical toxicity or side-effects, as reported previously (Perez-Castro et al, 2009;Motohashi, 2006;Vianna et al, 2001). The yeast system may contribute to elucidating the mechanisms of action and toxicity of the paralysing agents at the cellular level, and to the design of novel drugs, because the system can provide a genetic approach as well as easy and detailed evaluation.…”
Section: Compounds Shutting Down Intracellular Reactionssupporting
confidence: 57%
“…The clinical drugs are also known to have cytotoxic or neurotoxic effects (Kitagawa et al, 2004;Perez-Castro et al, 2009;Motohashi et al, 2006). At high concentrations, erythrocyte membrane and model membranes can be disrupted, and thus the toxic effects of drugs are considered to result from membrane lysis due to surfactant activities (Seeman, 1972;Kitagawa et al, 2004).…”
Section: Y Uesono Et Almentioning
confidence: 99%
“…Both amides, lidocaine and bupivacaine, are uncouplers of oxidative phosphorylation 34 that collapse the pH gradient and electrical potential across the inner mitochondrial membrane. 35 Consequently, lidocaine induces cell apoptosis or necrosis by recruiting the intrinsic mitochondrial pathway in neuronal or nonneuronal systems, [35][36][37] but at concentrations higher than those used in this study (usually above 5 mM). However, this form of toxicity may be prominent for lower concentrations of the more lipophilic agent, bupivacaine.…”
Section: Discussionmentioning
confidence: 94%
“…Furthermore local anaesthetics may cause neural membrane lysis due to detergent properties (Kitagawa et al 2004). The size of these effects is strongly influenced by a prolonged duration of exposure and higher concentration of the local anaesthetics, with in vitro the lowest neurotoxicty for procaine, mepivacaine and lidocaïne compared with ropivacaine and bupivacaine (Hogan 2008;Perez-Castro et al 2009), however most clinical relevant toxicity is attributed to high concentrations of lidocaïne (Zink & Graf 2003).…”
Section: Neurotoxicitymentioning
confidence: 99%